Try our corporate solution for free!
(212) 419-8286

Cancer crude incidence rate for females New Zealand 2018, by type

In 2018, the incidence rate of breast cancer was the highest compared to all other types of cancer for females in New Zealand, affecting 145.1 per 100,000 women per year. The occurrence of breast cancer in women in New Zealand was almost three times greater than the individual incidences of lung cancer, melanoma of the skin, and colon cancer.

Annual crude incidence rate of cancer for females in New Zealand in 2018, by type

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% discount until December 20th
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in

Release date

June 2019


New Zealand

Survey time period


Special properties

females of all ages

Supplementary notes

Note: Values were estimated by the source. Non-melanoma skin cancer was not included.

Only the leading 15 types of cancer are depicted here.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Women in New Zealand"

Further Content: You might find this interesting as well

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.